BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1520 related articles for article (PubMed ID: 20162517)

  • 1. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchopulmonary neuroendocrine tumors.
    Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
    Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
    Gálffy G
    Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine neoplasms of the larynx: an overview.
    Ferlito A; Silver CE; Bradford CR; Rinaldo A
    Head Neck; 2009 Dec; 31(12):1634-46. PubMed ID: 19536850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroendocrine tumors of the lung].
    Takei H; Asamura H
    Nihon Rinsho; 2004 May; 62(5):877-82. PubMed ID: 15148812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of neuroendocrine lung tumors.
    Sánchez de Cos Escuín J
    Arch Bronconeumol; 2014 Sep; 50(9):392-6. PubMed ID: 24685201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumours--challenges in the diagnosis and classification of pulmonary neuroendocrine tumours.
    den Bakker MA; Thunnissen FB
    J Clin Pathol; 2013 Oct; 66(10):862-9. PubMed ID: 23685279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants.
    Warren WH; Gould VE; Faber LP; Kittle CF; Memoli VA
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):819-25. PubMed ID: 2582209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M; Grossman A
    Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D; Yesner R
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pulmonary neuroendocrine tumours: state of the art and future developments.
    Gridelli C; Rossi A; Airoma G; Bianco R; Costanzo R; Daniele B; Chiara GD; Grimaldi G; Irtelli L; Maione P; Morabito A; Piantedosi FV; Riccardi F
    Cancer Treat Rev; 2013 Aug; 39(5):466-72. PubMed ID: 22818212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of pulmonary neuroendocrine proliferations and neoplasms.
    Benson RE; Rosado-de-Christenson ML; Martínez-Jiménez S; Kunin JR; Pettavel PP
    Radiographics; 2013 Oct; 33(6):1631-49. PubMed ID: 24108555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary neuroendocrine/carcinoid tumors: a review article.
    Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
    Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and novel therapeutics for neuroendocrine tumors of the lung.
    Jafri N; Salgia R
    J Biol Regul Homeost Agents; 2004; 18(3-4):275-90. PubMed ID: 15786694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy for pulmonary carcinoids.
    Marquez-Medina D; Popat S
    Lung Cancer; 2015 Nov; 90(2):139-47. PubMed ID: 26371699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.